Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Ceribell Inc (CBLL)

Ceribell Inc (CBLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ceribell to Participate in Upcoming March Investor Conferences GlobeNewswire - Wed Feb 18, 3:05PM CST

SUNNYVALE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 GlobeNewswire - Tue Feb 10, 3:05PM CST

SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution GlobeNewswire - Mon Jan 5, 7:00AM CST

SUNNYVALE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire - Tue Dec 30, 2025

SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)
Medical Breakthroughs: 5 AI Innovators Redefining What's Possible BayStreet.ca - Thu Dec 18, 2025

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER – Baystreet.ca News Commentary – The healthcare AI market reached $21.66 billion in 2025 and analysts now project growth to $110.61...

CBLL : 20.30 (+1.81%)
ONMD : 0.6763 (+1.08%)
VPT.VN : 0.115 (unch)
LNAI : 0.5772 (-1.35%)
ABSI : 2.78 (+2.96%)
VPTDF : 0.0845 (-0.82%)
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution GlobeNewswire - Tue Dec 9, 2025

SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates GlobeNewswire - Mon Nov 24, 2025

SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire - Wed Nov 19, 2025

SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum GlobeNewswire - Thu Nov 6, 2025

SUNNYVALE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)
Ceribell Reports Third Quarter 2025 Financial Results GlobeNewswire - Tue Nov 4, 2025

SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.30 (+1.81%)

Barchart Exclusives

S&P Futures Muted With U.S. PCE Inflation and GDP Data in Focus Barchart - 19 minutes ago
March S&P 500 E-Mini futures (ESH26) are trending up +0.01% this morning as investors assess the potential impact of conflict in the Middle East and await a raft of U.S. economic data, with particular attention on the Fed’s favorite inflation gauge and the first estimate of fourth-quarter GDP. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot